Image

Global Glycylcyclines Market – Industry Trends and Forecast to 2029

Pharmaceutical

Image

Global Glycylcyclines Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Apr 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Glycylcyclines Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 203.50 Billion
Diagram Market Size (Forecast Year) USD 257.79 Billion
Diagram CAGR %

Global Glycylcyclines Market, By Drug (Tygacil, Other), Application (Intraabdominal Infection, Skin and Structure Infection, Pneumonia, Skin or Soft Tissue Infection, Others), Dosage (Injection, Powder, Others), Route of Administration (Intravenous, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029

Glycylcyclines Market

Market Analysis and Size

In recent years, the glycylcyclines market is anticipated to grow rapidly during the forecast period. According to the United Nations' World Population Ageing Highlight 2020 study, the worldwide geriatric population is forecast to rise from 727 million in 2020 to 1.5 billion by 2050, a nearly two-fold increase, while the share of the geriatric population in 2020 was about 9.3%, and is expected to rise to 16% by 2050. As a result of the ageing population, the burden of infectious diseases is predicted to rise, complementing the market's expansion over the forecast period. All these factors lead to the high demand of glycylcyclines in the healthcare sector.

Data Bridge Market Research analyses that the glycylcyclines? market was valued at USD 203.5 million in 2021 and is expected to reach USD 257.79 million by 2029, registering a CAGR of 3.00% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Glycylcyclines, which are generated from tetracyclines, are a new class of antibiotics. They were created to address the problem of bacterial resistance to tetracyclines. Antibiotics that disrupt bacterial protein synthesis prevent bacteria from reproducing. They have a broad spectrum of activity against both gram-negative and gram-positive bacteria, but they are particularly effective against bacteria that are tetracycline resistant. Antibiotics containing glycylcycline are effective against methicillin-resistant staphylococci, penicillin-resistant Streptococcus pneumoniae, and vancomycin-resistant enterococci.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Drug (Tygacil, Other), Application (Intraabdominal Infection, Skin and Structure Infection, Pneumonia, Skin or Soft Tissue Infection, Others), Dosage (Injection, Powder, Others), Route of Administration (Intravenous, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Accord Healthcare (US), Amneal Pharmaceuticals LLC. (US), Apotex Inc. (Canada), Fresenius Kabi AG (Germany), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Meitheal Pharmaceuticals (US), AuroMedics Pharma LLC (US), Xellia Pharmaceuticals (US),  AstraZeneca (UK), Johnson & Johnson Private Limited (US), Amgen Inc. (US), Novartis AG (Switzerland), Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Sanofi (France), Merck & Co., Inc. (US), AbbVie Inc. (US), Sun Pharmaceutical Industries Ltd. (India), Eli Lilly and Company (US)

Market Opportunities

  • Increase in the number of emerging markets
  • Increase in the number of research and development activities
  • Surging drug approvals and launches

Glycylcyclines Market Dynamics

Drivers

  • Increasing prevalence of infectious diseases

The rising prevalence of infectious diseases is anticipated to influence the glycylcyclines market's growth. Intraabdominal infection, skin and structure infection, pneumonia, skin or soft tissue infection are the various medical ailments which are treated with the use of glycylcyclines.

  • Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of glycylcyclines market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the glycylcyclines market. Additionally, high disposable income and changing lifestyle of people will result in the expansion of glycylcyclines market. Sedentary lifestyle of people and rising pollution are the root causes behind the prevalence of various infectious diseases. Along with this, rising geriatric population and favourable reimbursement policies will enhance the growth rate of the market.

Opportunities

  • Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the glycylcyclines market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the glycylcyclines market growth during the forecast period.

Restraints/Challenges

On the other hand, the high cost associated with the drug development and distribution will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the glycylcyclines market. Additionally, side effects of glycylcyclines such as headache, photosensitivity, nausea, kidney diseases, tinnitus and hypersensitivity reactions will act as market restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This glycylcyclines market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the glycylcyclines market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Glycylcyclines market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Glycylcyclines Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. This can be ascribed to severe disruptions in their respective manufacturing and supply-chain operations therefore as consequence of multiple precautionary lockdowns and other limitations imposed by governments all over the world. The glycylcyclines market is no exception. Furthermore, consumer preferences has decreased as people are now much more concentrated on removing non-essential expenses from their budgets as the wider economic situation of most people has been adversely impacted by this outbreak. Over the forecast period, the aforementioned factors are likely to have a negative impact on the glycylcyclines market's revenue trajectory.

Global Glycylcyclines Market Scope

The glycylcyclines? market is segmented on the basis of drug, application, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug

  • Tygacil
  • Other

On the basis of drug, the global hepatic drugs market is segmented into tygacil, and other.

Application

  • Intraabdominal Infection
  • Skin and Structure Infection
  • Pneumonia
  • Skin or Soft Tissue Infection
  • Others

On the basis of application, the global hepatic drugs market is segmented into intraabdominal infection, skin and structure infection, pneumonia, skin or soft tissue infection and others.

Dosage

  • Injection
  • Powder
  • Others

On the basis of dosage, the glycylcyclines market is segmented into injection, powder and others.  

Route of Administration

  • Intravenous
  • Others

The route of administration segment for the glycylcyclines market is segmented into intravenous and others.

 End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

On the basis of end-users, the glycylcyclines market is segmented into hospitals, specialty clinics, homecare and others.

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

On the basis of distribution channel, the glycylcyclines market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.

Glycylcyclines Market Regional Analysis/Insights

The Glycylcyclines? market is analysed and market size insights and trends are provided by country, drug, application, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Glycylcyclines market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the glycylcyclines market because of the growing incidences of pneumonia in this region. Additionally, growing presence of major key players will further propel the market’s growth rate in this region.

Asia-Pacific are expected to grow during the forecast period due to rising healthcare expenditure and improvements in healthcare infrastructure in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Glycylcyclines Market Share Analysis

The Glycylcyclines market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to glycylcyclines market.

Some of the major players operating in the glycylcyclines market are:

  • Accord Healthcare (US)
  • Amneal Pharmaceuticals LLC. (US)
  • Apotex Inc. (Canada)
  • Fresenius Kabi AG (Germany)
  • Pfizer Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Meitheal Pharmaceuticals (US)
  • AuroMedics Pharma LLC (US)
  • Xellia Pharmaceuticals (US)
  • AstraZeneca (UK)
  • Johnson & Johnson Private Limited (US)
  • Amgen Inc. (US)
  • Novartis AG (Switzerland)
  • Abbott (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Sanofi (France)
  • Merck & Co., Inc. (US)
  • AbbVie Inc. (US)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Eli Lilly and Company (US)    


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Glycylcyclines Market size will be worth USD 257.79 million by 2029.
The Glycylcyclines Market growth rate is 3.00% by 2029.
Increasing prevalence of infectious diseases and Increasing investment for healthcare infrastructure are the growth drivers of the Glycylcyclines Market.
The drug, application, dosage, route of administration, end-users and distribution channel are the factors on which the Glycylcyclines Market research is based.
The major companies in the Glycylcyclines Market are Accord Healthcare (US), Amneal Pharmaceuticals LLC. (US), Apotex Inc. (Canada), Fresenius Kabi AG (Germany), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Meitheal Pharmaceuticals (US), AuroMedics Pharma LLC (US), Xellia Pharmaceuticals (US), AstraZeneca (UK), Johnson & Johnson Private Limited (US), Amgen Inc. (US), Novartis AG (Switzerland), Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Sanofi (France), Merck & Co., Inc. (US), AbbVie Inc. (US), Sun Pharmaceutical Industries Ltd. (India), Eli Lilly and Company (US).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials